Cargando…
Selinexor in Combination with Decitabine Attenuates Ovarian Cancer in Mice
SIMPLE SUMMARY: Ovarian cancer is frequently discovered in the later stages. Current treatment for advanced disease ovarian cancer is inadequate and survival is poor. Our goal was to investigate how treatment with targeted therapy decitabine and/or selinexor could improve ovarian cancer in mice, whe...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526280/ https://www.ncbi.nlm.nih.gov/pubmed/37760508 http://dx.doi.org/10.3390/cancers15184541 |